These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37243325)

  • 1. A single administration of FGF2 after renal ischemia-reperfusion injury alleviates post-injury interstitial fibrosis.
    Tan X; Tao Q; Yin S; Fu G; Wang C; Xiang F; Hu H; Zhang S; Wang Z; Li D
    Nephrol Dial Transplant; 2023 Oct; 38(11):2537-2549. PubMed ID: 37243325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubular cells produce FGF2 via autophagy after acute kidney injury leading to fibroblast activation and renal fibrosis.
    Livingston MJ; Shu S; Fan Y; Li Z; Jiao Q; Yin XM; Venkatachalam MA; Dong Z
    Autophagy; 2023 Jan; 19(1):256-277. PubMed ID: 35491858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 2 protects against renal ischaemia/reperfusion injury by attenuating mitochondrial damage and proinflammatory signalling.
    Tan XH; Zheng XM; Yu LX; He J; Zhu HM; Ge XP; Ren XL; Ye FQ; Bellusci S; Xiao J; Li XK; Zhang JS
    J Cell Mol Med; 2017 Nov; 21(11):2909-2925. PubMed ID: 28544332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats.
    Martínez-Rojas MÁ; Balcázar H; Ponce-Nava MS; González-Soria I; Marquina-Castillo B; Pérez-Villalva R; Bobadilla NA
    J Physiol; 2024 Apr; 602(8):1835-1852. PubMed ID: 38529522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
    Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy activates EGR1 via MAPK/ERK to induce FGF2 in renal tubular cells for fibroblast activation and fibrosis during maladaptive kidney repair.
    Livingston MJ; Zhang M; Kwon SH; Chen JK; Li H; Manicassamy S; Dong Z
    Autophagy; 2024 May; 20(5):1032-1053. PubMed ID: 37978868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan oligosaccharide attenuates acute kidney injury and renal interstitial fibrosis induced by ischemia-reperfusion.
    Yin S; Liu J; Zhao X; Dong H; Cao Y; Zhang S; Dong X; Zhang G; Jin S; Shi W; Xiang F; Gong J; Wang Z; Han B; Zhang N; Tan X; Wang Z
    Ren Fail; 2023 Dec; 45(1):2238831. PubMed ID: 37482748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury.
    Xie ZY; Dong W; Zhang L; Wang MJ; Xiao ZM; Zhang YH; Shi WX; Huang Y; Yang Y; Li CL; Fu L; Zhao XC; Li RZ; Li ZL; Chen YH; Ye ZM; Liu SX; Dong Z; Liang XL
    Acta Pharmacol Sin; 2022 Aug; 43(8):2081-2093. PubMed ID: 34937917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gremlin1 and TGF-β1 protect kidney tubular epithelial cells from ischemia-reperfusion injury through different pathways.
    Gao X; Han L; Yao X; Ma L
    Int Urol Nephrol; 2022 Jun; 54(6):1311-1321. PubMed ID: 34633599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective effects of laxative linaclotide: Inhibition of acute kidney injury and fibrosis in a rat model of renal ischemia-reperfusion.
    Hitaka Y; Isoyama N; Tsuji S; Honda T; Nakayama Y; Yamaguchi M; Nakamura K; Hirata H; Shiraishi K; Asagiri M
    Biochem Biophys Res Commun; 2024 May; 709():149709. PubMed ID: 38554603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLF4 initiates sustained YAP activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury.
    Xu D; Chen PP; Zheng PQ; Yin F; Cheng Q; Zhou ZL; Xie HY; Li JY; Ni JY; Wang YZ; Chen SJ; Zhou L; Wang XX; Liu J; Zhang W; Lu LM
    Acta Pharmacol Sin; 2021 Mar; 42(3):436-450. PubMed ID: 32647339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF-1R inhibition attenuates ischemia-induced renal injury and fibrosis by reducing Ly6C
    Deng X; Yang Q; Wang Y; Zhou C; Guo Y; Hu Z; Liao W; Xu G; Zeng R
    Int Immunopharmacol; 2020 Nov; 88():106854. PubMed ID: 32771945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.
    Lok SWY; Yiu WH; Zou Y; Xue R; Li H; Ma J; Chen J; Chan LYY; Lai KN; Tang SCW
    Nephrol Dial Transplant; 2023 Sep; 38(10):2232-2247. PubMed ID: 36914214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockout of Zeb2 ameliorates progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia-reperfusion injury.
    Inotani S; Taniguchi Y; Nakamura K; Nishikawa H; Matsumoto T; Horino T; Fujimoto S; Sano S; Yanagita M; Terada Y
    Nephrol Dial Transplant; 2022 Feb; 37(3):454-468. PubMed ID: 34724064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mouse model of chronic kidney disease transitioned from ischemic acute kidney injury.
    Wei J; Zhang J; Wang L; Jiang S; Fu L; Buggs J; Liu R
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F286-F295. PubMed ID: 31116604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis.
    Chen Y; Lin L; Tao X; Song Y; Cui J; Wan J
    BMC Nephrol; 2019 Mar; 20(1):106. PubMed ID: 30922260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
    Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of contralateral nephrectomy timing and ischemic conditions on kidney fibrosis after unilateral kidney ischemia-reperfusion injury.
    Zhang J; Shen R; Lin H; Pan J; Feng X; Lin L; Niu D; Hou Y; Su X; Wang C; Wang L; Qiao X
    Ren Fail; 2022 Dec; 44(1):1568-1584. PubMed ID: 36154902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of NAD+ boosting on kidney ischemia-reperfusion injury.
    Morevati M; Egstrand S; Nordholm A; Mace ML; Andersen CB; Salmani R; Olgaard K; Lewin E
    PLoS One; 2021; 16(6):e0252554. PubMed ID: 34061900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthine oxidase/NADPH oxidase inhibition by hydralazine attenuates acute kidney injury and prevents the transition of acute kidney injury to chronic kidney disease.
    Chiang CH; Chen C; Fang SY; Lin SC; Chen JW; Chang TT
    Life Sci; 2023 Aug; 327():121863. PubMed ID: 37331504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.